The 4th Chronic Kidney Disease Drug Development Summit provides the opportunity to connect with renal leaders. The event is dedicated to accelerating the frontier of preventative and regenerative therapies to meaningfully target kidney disease and enlighten opportunities for indication expansion into rare renal disorders.
Will you be attending? If so, reach out to Matthew Reabold at [email protected] to discuss and/or schedule a time to meet with our scientific leaders.
Three members of George Clinicals kidney and metabolic scientific leadership team will be in attendance: Hiddo Heerspink, Jonathan Barrett and Roberto Pecoits-Filho.
Professor Barrett will be presenting on Tuesday, March 1st from 3-6 pm on Elucidating the Pathogenesis of IgA Nephropathy & Learning from Clinical Updates to Identify Potential Therapeutic Targets in IgAN.
Professor Heerspink will be presenting on Wednesday, March 2nd during two sessions:
In addition, this year’s event provides the opportunity to hear from industry leaders that will share their expertise and cover topics including:
Professor Heerspink focuses on optimizing treatment strategies, finding new CKD therapeutic approaches and personalized medicine. He is Professor of Clinical Trials and Personalized Medicine and a clinical trialist at the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen and Clinical Pharmacologist University Medical Center Groningen. His expertise includes clinical trial design and methodological aspects and statistical analyses of clinical trials.
Professor Barratt focuses on glomerular disease, multi-system renal disease and complications of CKD, in particular renal associated anemia. He is The Mayer Professor of Renal Medicine & Honorary Consultant Nephrologist and leads the Renal Research Group within the College of Life Sciences University of Leicester, UK. He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the International IgA Nephropathy Network.
Dr. Pecoits-Filho is a practicing Nephrologist and clinical investigator focused on evolving the way CKD patients are treated in day-to-day clinical practice by integrating observational research with clinical trials. He is the Scientific Director of the DOPPS program at Arbor Research Collaborative for Health, Michigan, and a professor of Medicine at the Pontifical Catholic University of Paraná, Brazil.
Hyatt Regency Boston
1 Ave de Lafayette
Boston, MA
USA
Meet with George Clinical! Contact us to schedule a time now.
